seed
Stage
1
Investors
About
Bioceltix develops veterinary biological drugs based on allogenic mesenchymal stem cells (MSC) to treat inflammatory and autoimmune diseases in companion animals such as dogs and horses.
Explore Bioceltix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.